Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
225 |
|
| Actual shortage: | 3 (1%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 3 (1%) | |
| Resolved: | 217 (96%) | |
Discontinuation Reports |
27 |
|
| To be discontinued: | 1 (4%) | |
| Discontinued: | 26 (96%) | |
| Reversed: | 0 (0%) | |
Late reports |
14 (6%) |
|
Overdue reports |
3 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ARTISS | 40MCMOL 4UNIT 3000KIU 125MG | SOLUTION | Resolved | 2022-07-14 | 2022-07-20 | 164616 |
| BREVIBLOC INJECTION 10MG/ML | 10MG | SOLUTION | Resolved | 2020-10-20 | 2020-11-10 | 126749 |
| BREVIBLOC INJECTION 10MG/ML | 10MG | SOLUTION | Resolved | 2018-03-15 | 2018-05-16 | 43037 |
| BREVIBLOC PREMIXED INJECTION | 10MG | SOLUTION | Resolved | 2017-07-31 | 2017-08-09 | 17549 |
| BREVIBLOC PREMIXED INJECTION | 10MG | SOLUTION | Resolved | 2019-08-16 | 2019-09-17 | 91707 |
| BREVIBLOC PREMIXED INJECTION | 10MG | SOLUTION | Resolved | 2019-12-17 | 2020-01-03 | 101500 |
| BREVIBLOC PREMIXED INJECTION | 10MG | SOLUTION | Resolved | 2023-05-23 | 2023-06-29 | 192906 |
| BREVIBLOC PREMIXED INJECTION | 10MG | SOLUTION | Resolved | 2024-10-24 | 2025-03-13 | 241095 |
| BUPIVACAINE HYDROCHLORIDE INJECTION, USP | 7.5MG | SOLUTION | Avoided shortage | 2023-11-17 | 2024-08-12 | 210780 |
| CAELYX | 2MG | SUSPENSION | Resolved | 2024-06-06 | 2024-08-30 | 229782 |
| CALCIUM GLUCONATE INJECTION, USP 10% | 100MG | SOLUTION | Actual shortage | 2024-09-26 | 2025-01-14 | 238556 |
| CEFAZOLIN INJECTION, USP | 20MG | SOLUTION | Anticipated shortage | 2025-04-07 | 2025-04-07 | 254442 |
| CEFAZOLIN INJECTION, USP | 20MG | SOLUTION | Anticipated shortage | 2025-04-07 | 2025-04-07 | 254446 |
| CEFTRIAXONE INJECTION, USP | 1000MG | SOLUTION | Resolved | 2024-08-15 | 2024-08-24 | 235267 |
| CEFTRIAXONE INJECTION, USP | 2000MG | SOLUTION | Resolved | 2025-01-14 | 2025-02-01 | 247690 |
| CEFTRIAXONE INJECTION, USP | 1000MG | SOLUTION | Resolved | 2022-06-15 | 2022-08-17 | 162666 |
| CLINDAMYCIN INJECTION IN 5% DEXTROSE | 600MG | SOLUTION | Resolved | 2023-02-06 | 2023-11-01 | 183714 |
| CLINDAMYCIN INJECTION IN 5% DEXTROSE | 600MG | SOLUTION | Resolved | 2022-12-02 | 2022-12-12 | 177050 |
| CLINDAMYCIN INJECTION IN 5% DEXTROSE | 600MG | SOLUTION | Resolved | 2020-09-02 | 2020-09-17 | 123592 |
| CLINDAMYCIN INJECTION IN 5% DEXTROSE | 900MG | SOLUTION | Resolved | 2023-02-06 | 2023-11-01 | 183717 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLINIMIX E | 205MG 261MG 58.5MG 24MG 16.6G 365MG 280MG 290MG 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG | SOLUTION | Discontinued | 2020-06-22 | 2022-06-30 | 118607 |
| CLINIMIX E | 90MG 210MG 20MG 261MG 58.5MG 24MG 205MG 20G 310MG 310MG 290MG 290MG 1.04G 1.04G 520MG 240MG 230MG 220MG 210MG | SOLUTION | Discontinued | 2020-06-22 | 2021-03-26 | 118604 |
| CLINOLEIC 20% | 4% 16% | EMULSION | Discontinued | 2017-04-04 | 2018-01-01 | 5289 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91385 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91382 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91378 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 900MG 300MG | SOLUTION | Discontinued | 2020-11-26 | 2021-02-02 | 128947 |